Acquisition: GE Healthcare acquires U-Systems' breast ultrasound screening technology

November 9, 2012 by MassDevice staff

GE Healthcare acquires ultrasound breast cancer screening devices maker U-Systems, which could help GE Healthcare expand its breast care portfolio from screening to monitoring.

mergers and acquisitions illustration

Healthcare giant GE Healthcare (NYSE:GE) acquired U-Systems and with it the 1st FDA-approved ultrasound-based dense-tissue mammogram adjunct, the Somo•v automated breast ultrasound.

The Somo•v ABUS is the only automated system in the U.S., Canada and 27 European Union countries  indicated for use in combination with standard mammography for asymptomatic women with dense breast tissue.

The companies did not diclose the financial terms of the acquisition.

Sign up to get our free newsletters delivered right to your inbox.

Sunnyvale, Calif.-based U-Systems landed expanded FDA approval for its Somo•v ABUS in September 2012 for dense breast tissue screening. The device already had clearance for diagnostic use alongside mammography and has had CE Mark approval since September 2010.